InvestmentUpdated on 28 August 2025
First-in-Class Diagnostics
About
We are raising a seed round to secure intellectual property, complete clinical validation, and accelerate the development of our first-in-class diagnostic platform for gluten-associated diseases. Despite affecting millions worldwide, current diagnostic solutions are slow, unreliable, or unavailable — leaving patients and healthcare providers without effective tools for early detection and management.
With IP protection underway, we are now focused on final validation studies, regulatory preparation, and strategic partnerships to enable a fast market entry.
The seed funding will allow us to build the foundation for scale: strengthening our IP portfolio, advancing product development, and positioning the company for Series A and beyond.
Stage
- Seed and Development
- Startup
Organisation
Similar opportunities
Partnership
Bas Klaver ✅
Business Development at Demcon High-Tech Systems
Enschede, Netherlands
Service
Qualification & Validation Services
- Consulting
- Manufacturing
- Development stages and support fuctions - Data management and analytics
- Development stages and support fuctions - Development and (GMP) manufacturing
daniel lüscher
CEO at QBDC GmbH
Nusshof, Switzerland
Service
Contract manufacturing for microfluidic devices
- Manufacturing
- High Tech Systems & Materials - Chip design
- Innovative human-based test models - Organ-on-Chip
Bas-Jan Hoogenberg
Director at Bondus
Zwolle, Netherlands